India–US Trade Talks Hit a 'Plateau': What the Tariff Standoff Means for Exporters This Quarter

India's trade negotiations with the United States have stalled again. On 6 October 2026, Finance Minister Nirmala Sitharaman said the talks had reached a "plateau" with little room for give and take, and US Trade Representative Jamieson Greer indicated that a deal was not "imminent." For exporters shipping to the United States — India's single largest export market — the headline is uncertainty: the tariff picture on the corridor remains unsettled, and the political calendar offers no clean resolution date. This is an analytical read on where things stand and how to manage the risk, not a change in any specific duty rate.

What's Happening

The US is India's biggest export destination, with Indian goods exports to the US reported at about USD 42.79 billion in April–August of the current year, up from roughly USD 40.39 billion a year earlier. Despite that volume, the bilateral relationship has been through a turbulent stretch on trade.

Several threads are tangled together:

• The tariff level itself is unsettled. A punitive tariff was imposed on Indian goods in August 2025 after an earlier round of talks collapsed. A framework understanding reached in February 2026 was reported to cut a punitive component from 50% toward the high teens. More recently, US courts curbed the use of emergency powers for sweeping tariffs, which reporting associates with a lower baseline rate on Indian goods. The net effective duty on any given product is therefore genuinely hard to state with confidence right now.
• A Russian-oil penalty looms separately. A US law reportedly allows additional tariffs of up to 100% tied to India's continued purchases of Russian crude, which have not been significantly reduced. This is a distinct lever from the general reciprocal tariff.
• A Section 301 investigation is unfinished. The US has not concluded a probe into alleged excess industrial capacity across several countries, so the final tariff treatment of Indian goods is not yet fixed.
• Carve-outs exist. Indian officials have said major categories such as generic pharmaceuticals and smartphones are not subject to the baseline levy — consistent with the separate Section 232 action on branded/patented drugs that has kept Indian generics exempt for now.

Why the Talks Stalled

The sticking points are substantive, not merely procedural. India wants to keep sensitive agriculture — dairy, poultry, rice and wheat — out of market-opening commitments, and is seeking more certainty on US tariff treatment before offering concessions. Washington wants India to curb Russian oil imports and to move toward large purchase commitments. Reporting also points to bilateral friction beyond trade that has cooled the atmosphere. Sitharaman's "plateau" framing and Greer's "not imminent" signal that neither side expects a breakthrough in the immediate term.

Who's Affected

The exposure is concentrated in India's labour-intensive, price-sensitive export sectors to the US: textiles and apparel, shrimp and seafood, gems and diamonds, carpets, and footwear, where even a modest duty differential can move orders to competitors. Engineering goods and chemicals exporters also watch the reciprocal-tariff track closely. Generic pharma and electronics/smartphone exporters are comparatively insulated under current carve-outs, but that comfort is contingent on reviews that could change.

What India-to-US Exporters Should Do Now

• Price per product, not per headline. Do not assume a single tariff number applies to your goods. Confirm the current effective US duty for your specific HS line and country-of-origin status before quoting.
• Stress-test your margins. Model orders at more than one tariff scenario — including an adverse Russian-oil-linked outcome — so a sudden change does not turn a profitable contract into a loss.
• Firm up contract protections. Use duty-adjustment, force-majeure-style and renegotiation clauses so tariff shifts during the order cycle are shared, not absorbed alone.
• Diversify destinations. Accelerate development of non-US markets — the EU, Gulf/CEPA partners, UK and others — to reduce single-market dependence while the corridor is volatile.
• Watch the near-term political calendar. Reported engagements, including a possible senior US visit to India later in October 2026 and leader-level contact around the December G20, could move sentiment quickly in either direction.
• Keep origin documentation airtight. In a tariff-sensitive environment, clean proof of Indian origin and correct classification protect you against disputes and reclassification risk.

The Bigger Picture

The lesson of the past year is that tariff reductions on this corridor have proven reversible and that framework understandings are non-binding and open to revision. Exporters who treat any single tariff figure as permanent are exposed; those who build flexibility into pricing, contracts and market mix are better placed to ride out the swings. The direction of travel — toward some negotiated settlement — still looks more likely than not over time, but the timing and the final tariff architecture remain open questions.

Frequently Asked Questions

What tariff will my goods face shipping to the US today? It depends on the product and the current state of several overlapping measures. Verify the effective rate for your specific HS code at the time of shipment rather than relying on a general figure.

Are Indian generic drugs and smartphones still exempt? They have been reported as outside the baseline levy, and Indian generics remain outside the separate Section 232 branded-drug tariff for now. Both positions are subject to review.

Is the 100% Russian-oil tariff in force? It is described as an available legal lever tied to India's oil purchases, not a blanket rate currently applied to all goods. Treat it as a material downside risk and monitor developments.

When will the talks conclude? No date is set. Officials have signalled no imminent deal; watch for high-level engagements in the coming weeks.

Conclusion

The India–US trade corridor is in a holding pattern: large in value, unsettled on tariffs, and without a near-term deal. For exporters, the practical response is not to guess the politics but to manage the exposure — price per product, protect contracts, diversify markets and keep documentation clean — so the business is resilient whichever way the negotiations break.

This is an analytical summary for general guidance only and not a statement of any specific duty rate. Verify the current US tariff treatment of your goods with official US Customs and Border Protection / USTR sources and your buyer before making commercial commitments.